Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-22-079892
Filing Date
2022-12-15
Accepted
2022-12-15 06:13:17
Documents
3
Period of Report
2022-12-15

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea170247-6k_alterity.htm 6-K 12332
2 CHANGE OF DIRECTOR'S INTEREST NOTICE X 4 ea170247ex99-1_alterity.htm EX-99.1 135501
3 GRAPHIC ex99-1_001.jpg GRAPHIC 1649
  Complete submission text file 0001213900-22-079892.txt   151343
Mailing Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000
Business Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000 61 3 9349 4906
ALTERITY THERAPEUTICS LTD (Filer) CIK: 0001131343 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-49843 | Film No.: 221463606
SIC: 2834 Pharmaceutical Preparations